U.S. markets close in 1 hour 45 minutes

  • S&P 500

    4,435.49
    +3.14 (+0.07%)
     

  • Dow 30

    35,249.43
    +147.58 (+0.42%)
     

  • Nasdaq

    14,773.01
    -87.17 (-0.59%)
     

  • Russell 2000

    2,240.65
    +5.85 (+0.26%)
     

  • Crude Oil

    68.56
    +2.08 (+3.13%)
     

  • Gold

    1,732.40
    +5.90 (+0.34%)
     

  • Silver

    23.38
    +0.11 (+0.46%)
     

  • EUR/USD

    1.1723
    -0.0017 (-0.14%)
     

  • 10-Yr Bond

    1.3420
    +0.0250 (+1.90%)
     

  • GBP/USD

    1.3837
    -0.0014 (-0.10%)
     

  • USD/JPY

    110.5900
    +0.2850 (+0.26%)
     

  • BTC-USD

    45,177.77
    -731.61 (-1.59%)
     

  • CMC Crypto 200

    1,113.37
    +870.69 (+358.78%)
     

  • FTSE 100

    7,161.04
    +28.74 (+0.40%)
     

  • Nikkei 225

    27,888.15
    +68.11 (+0.24%)
     
Webinar:

Yahoo Finance Plus presents 'How to invest during uncertainty as Delta cases spike'

Schwab's Liz Ann Sonders joins Jared Blikre to break down strategies amid elevated risk on Wed, 8/11 at 12PM ET.

Bitcoin Investment Outflows Continue for Fifth Consecutive Week

  • Oops!
    Something went wrong.
    Please try again later.
Savannah Fortis
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BeInCrypto –

CoinShares released data this past Monday which shows a consistent outflow of Bitcoin investment products and funds. 

According to data from CoinShares, a trusted digital asset manager, investment products and funds related to bitcoin logged outflows for five consecutive weeks. The data comes as industry-changing regulations sit on the desks of regulators in the U.S.

The potential upheaval of industry operations has investors and others functioning within the space skeptical of what is to come. 

This story was seen first on BeInCrypto Join our Telegram Group and get trading signals, a free trading course and more stories like this on BeInCrypto

Recommended Stories

  • Bitcoin’s Weekend Moves Again Drive Coinbase’s Monday Trading

    (Bloomberg) -- The common shares of public companies that operate exchanges usually rise and fall with the popularity of the stuff that trades on them. Coinbase Global Inc. takes that correlation to a whole other level.For the biggest U.S. cryptocurrency exchange, that means looking at Bitcoin, specifically, the largest digital asset’s weekend moves, which can give investors an insight into how Coinbase might open for trading on the Nasdaq any given Monday.Take, for instance, this weekend with B

  • Here’s Why Magnite, Inc. (MGNI) Became Part of Alger’s Top Detractor List

    Alger, an investment management firm, published its “Alger Mid Cap Focus Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. During the quarter, the largest portfolio sector weightings for the fund were Information Technology and Industrials. The largest sector overweight was Industrials. Class Z shares of the Alger Mid […]

  • Is MARA Stock A Buy After Fidelity Buys Stake? Here's What Earnings, Marathon Digital Stock Chart Show

    Marathon Digital stock has been volatile as Bitcoin adoption grows. Here’s what the fundamentals and technical analysis say about the stock.

  • What to Expect When Nio Reports Earnings

    Chinese electric-vehicle maker Nio (NYSE: NIO) will report its second-quarter earnings results after the U.S. markets close on Wednesday, Aug. 11. Wall Street analysts polled by Thomson Reuters expect Nio to report a loss of $0.11 per American depositary share, on average, on revenue of $1.28 billion. In what was a better-than-expected result at the time, Nio lost $0.16 per share on revenue of $526.4 million in the second quarter of 2020.

  • Why Moderna Stock Is Slipping Today

    Shares of Moderna (NASDAQ: MRNA) were slipping 5.8% as of 10:52 a.m. EDT on Tuesday. The decline came after Bank of America analyst Geoff Meacham wrote to investors that the stock's valuation has gone "from unreasonable to ridiculous." Meacham reiterated an underperform rating for Moderna with a price target of $115, roughly 75% below the current price of the biotech's shares.

  • 3 Things I'm looking For in Upstart's Earnings

    Earnings season can be overwhelming. Company after company delivers a flood of numbers and shares often move up or down violently. Revenue and income numbers are always the go to explanations of Wall Street's reaction, but it's important to dig deeper.

  • Is Roku Inc. (ROKU) A Smart Long-Term Buy?

    LRT Capital Management, an investment management firm, published its second-quarter 2021 investor letter – a copy of which can be downloaded here. A return of +29.68% was recorded by the LRT Economic Moat strategy for the Q2 of 2021, extending its 12-month returns to +42.18%. You can take a look at the fund’s top 5 holdings […]

  • 3 Cathie Wood Tech Stocks Down 25% That I'd Still Buy

    As the founder, CEO, and lead portfolio manager for ARK Invest, Cathie Wood is one busy person. Wood has excelled in each of these roles, and was named the best stock picker in 2020 by Bloomberg News. Here are three growth stocks from her portfolio down 25% (or more) from their 52-week highs that are positioned for long-term success.

  • 10 Best Lithium and Phosphate Stocks to Buy Now

    In this article, we discuss the 10 best lithium and phosphate stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Lithium and Phosphate Stocks to Buy Now. The global efforts towards decarbonization have accelerated in the past few years with the United States […]

  • 3 Big Takeaways From Workhorse Group's Earnings Report

    Workhorse's weary investors might finally have something to cheer -- and it's not the U.S. Postal Service.

  • 10 Best EV Materials Stocks to Buy

    In this article, we discuss the 10 best EV materials stocks to buy. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best EV Materials Stocks to Buy. The increase in demand for electric vehicles (EVs) around the world over the past few years has also given a […]

  • Moderna’s stock price is ‘ridiculous,’ says BofA analyst

    Shares of Moderna Inc. have so much that the biotechnology company's valuation is "unjustifiable on a fundamental basis," said analyst Geoff Meacham on Tuesday, as his analysis suggests the stock could fall more than 75% from current levels.

  • Exact Sciences (EXAS), A Top Detractor in RiverPark’s Q2 Results

    RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. The RiverPark Large Growth Fund (the “Fund”) returned 13.1% for the second quarter of 2021, while its benchmarks, the S&P 500 Total Return Index (“S&P”) advanced 8.5%, the Russell […]

  • 12 Best Artificial Intelligence Stocks To Invest In Right Now

    In this article, we will be looking at 12 best artificial intelligence stocks to invest in right now. To skip our detailed analysis of these stocks and the artificial intelligence industry, you can go directly to see the 5 Best Artificial Intelligence Stocks To Invest In Right Now. The COVID-19 pandemic hastened the advent of AI […]

  • Why Moderna, BioNTech, and Novavax Stock Soared Today

    Moderna's shares received a boost from news that its COVID vaccine was granted provisional registration by Australia's Therapeutic Goods Administration. Moderna has agreements in place to potentially supply as many as 25 million doses of its vaccine to the Australian government by 2022. Shares of Moderna, BioNTech, and Novavax rose sharply on Monday.

  • Why GameStop Is Falling Today

    Shares of GameStop (NYSE: GME) are down 1% in late morning trading Tuesday after opening the day almost 4% higher. This followed the chairman and CEO of AMC Entertainment (NYSE: AMC) saying he was pursuing a collaboration with the video game retailer. GameStop and AMC are the two premiere meme stocks on the market.

  • Why Shares of Vaxart Are Soaring Today

    Shares of clinical-stage vaccine developer Vaxart (NASDAQ: VXRT) are up again today, gaining 12.34% to $9.83 apiece as of 2:30 p.m. EDT. The stock is up 21% over the past five trading days due to greater capital inflows after the company released encouraging second-quarter earnings on Aug. 5. Vaxart managed to raise $36.2 million during the quarter via issuing new stock -- bringing its cash balance to $177.3 million.

  • Zynga Inc. (NASDAQ:ZNGA) is Fighting an Uphill Battle to Deliver Long-Term Growth

    There's been a notable change in appetite for Zynga Inc. (NASDAQ:ZNGA) shares in the week since its quarterly report, with the stock down 19% pre-market to US$8.11. We want to take a look at the growth prospects for Zynga and put them into context with long term expectations.

  • Why Oak Street Health Stock Is Sinking Today

    CEO Mike Pykosz said that Oak Street Health had higher medical costs in the second quarter. Pykosz stated that Oak Street Health thinks the higher medical costs will only be a temporary issue. Oak Street Health plans to add between 46 and 48 new centers for 2021.

  • Vuzix (VUZI) Q2 2021 Earnings Call Transcript

    Now I would like to turn the call over to Ed McGregor, director of investor relations at Vuzix. With us today are Vuzix's CEO, Paul Travers; and CFO, Grant Russell. Before I turn the call over to Paul, I would like to remind you that on this call, management's prepared remarks may contain forward-looking statements, which are subject to risks and uncertainties, and management may make additional forward-looking statements during the question-and-answer session.